WO2008031501A3 - 2-phenoxynikotinsäure-derivate und ihre verwendung - Google Patents
2-phenoxynikotinsäure-derivate und ihre verwendung Download PDFInfo
- Publication number
- WO2008031501A3 WO2008031501A3 PCT/EP2007/007575 EP2007007575W WO2008031501A3 WO 2008031501 A3 WO2008031501 A3 WO 2008031501A3 EP 2007007575 W EP2007007575 W EP 2007007575W WO 2008031501 A3 WO2008031501 A3 WO 2008031501A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phenoxy
- acid derivative
- nicotine acid
- prophylaxis
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/440,725 US20100298221A1 (en) | 2006-09-12 | 2007-08-30 | 2-phenoxy nicotine acid derivative and use thereof |
CA002662879A CA2662879A1 (en) | 2006-09-12 | 2007-08-30 | 2-phenoxynicotinic acid derivatives and use thereof |
EP07801996A EP2066635A2 (de) | 2006-09-12 | 2007-08-30 | 2-phenoxynikotinsäure-derivate und ihre verwendung |
JP2009527717A JP2010507569A (ja) | 2006-09-12 | 2007-08-30 | 2−フェノキシニコチン酸誘導体およびそれらの使用 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006043520.6 | 2006-09-12 | ||
DE102006043520A DE102006043520A1 (de) | 2006-09-12 | 2006-09-12 | 2-Phenoxynikotinsäure-Derivate und ihre Verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008031501A2 WO2008031501A2 (de) | 2008-03-20 |
WO2008031501A3 true WO2008031501A3 (de) | 2011-04-14 |
Family
ID=38681456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/007575 WO2008031501A2 (de) | 2006-09-12 | 2007-08-30 | 2-phenoxynikotinsäure-derivate und ihre verwendung |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100298221A1 (de) |
EP (1) | EP2066635A2 (de) |
JP (1) | JP2010507569A (de) |
AR (1) | AR062586A1 (de) |
CA (1) | CA2662879A1 (de) |
CL (1) | CL2007002637A1 (de) |
DE (1) | DE102006043520A1 (de) |
PE (1) | PE20081371A1 (de) |
TW (1) | TW200829553A (de) |
UY (1) | UY30582A1 (de) |
WO (1) | WO2008031501A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007042754A1 (de) | 2007-09-07 | 2009-03-12 | Bayer Healthcare Ag | Substituierte 6-Phenylnikotinsäuren und ihre Verwendung |
EP3593802A3 (de) | 2010-05-26 | 2020-03-25 | Satiogen Pharmaceuticals, Inc. | Gallensäurerückflusshemmer zur behandlung von diabetes, adipositas und entzündlichen magen-darm-erkrankungen |
BR112014010228B1 (pt) | 2011-10-28 | 2020-09-29 | Lumena Pharmaceuticals Llc | Uso de inibidores de reciclagem de ácido biliar para o tratamento de hipercolemia e doença hepática colestática |
PL2771003T3 (pl) | 2011-10-28 | 2017-10-31 | Lumena Pharmaceuticals Llc | Inhibitory ponownego wykorzystania kwasów żółciowych do leczenia pediatrycznych cholestatycznych chorób wątroby |
RU2015139732A (ru) | 2013-03-15 | 2017-04-24 | ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи | Ингибиторы рециркуляции желчных кислот для лечения пищевода барретта и гастроэзофагеальной рефлюксной болезни |
BR112015023646A2 (pt) | 2013-03-15 | 2017-07-18 | Lumena Pharmaceuticals Inc | inibidores de ácidos biliares de reciclagem para tratamento de colangite esclerosante primária e doença inflamatória do intestino |
AU2020221834A1 (en) | 2019-02-12 | 2021-09-02 | Mirum Pharmaceuticals, Inc. | Genotype and dose-dependent response to an ASBTI in patients with bile salt export pump deficiency |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003082191A2 (en) * | 2002-03-28 | 2003-10-09 | Merck & Co., Inc. | Substituted 2,3-diphenyl pyridines |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005027150A1 (de) * | 2005-03-12 | 2006-09-28 | Bayer Healthcare Ag | Pyrimidincarbonsäure-Derivate und ihre Verwendung |
-
2006
- 2006-09-12 DE DE102006043520A patent/DE102006043520A1/de not_active Withdrawn
-
2007
- 2007-08-29 AR ARP070103836A patent/AR062586A1/es not_active Application Discontinuation
- 2007-08-30 JP JP2009527717A patent/JP2010507569A/ja active Pending
- 2007-08-30 CA CA002662879A patent/CA2662879A1/en not_active Abandoned
- 2007-08-30 US US12/440,725 patent/US20100298221A1/en not_active Abandoned
- 2007-08-30 WO PCT/EP2007/007575 patent/WO2008031501A2/de active Application Filing
- 2007-08-30 EP EP07801996A patent/EP2066635A2/de not_active Withdrawn
- 2007-09-11 TW TW096133787A patent/TW200829553A/zh unknown
- 2007-09-11 CL CL200702637A patent/CL2007002637A1/es unknown
- 2007-09-11 PE PE2007001214A patent/PE20081371A1/es not_active Application Discontinuation
- 2007-09-11 UY UY30582A patent/UY30582A1/es not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003082191A2 (en) * | 2002-03-28 | 2003-10-09 | Merck & Co., Inc. | Substituted 2,3-diphenyl pyridines |
Also Published As
Publication number | Publication date |
---|---|
TW200829553A (en) | 2008-07-16 |
UY30582A1 (es) | 2008-05-02 |
AR062586A1 (es) | 2008-11-19 |
DE102006043520A1 (de) | 2008-03-27 |
EP2066635A2 (de) | 2009-06-10 |
PE20081371A1 (es) | 2008-10-16 |
CA2662879A1 (en) | 2008-03-20 |
WO2008031501A2 (de) | 2008-03-20 |
CL2007002637A1 (es) | 2008-03-14 |
JP2010507569A (ja) | 2010-03-11 |
US20100298221A1 (en) | 2010-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008104306A3 (de) | Substituierte 4-aryl-1,4-dihydro-1,6-naphthyridinamide und ihre verwendung | |
WO2008113469A8 (de) | Substituierte imidazo- und triazolopyrimidine | |
WO2008031501A3 (de) | 2-phenoxynikotinsäure-derivate und ihre verwendung | |
WO2009018816A3 (de) | Verbesserte arzneimittelbeschichtete medizinprodukte, deren herstellung und verwendung | |
WO2009145456A3 (ko) | 헤테로사이클 유도체 | |
WO2009068214A3 (de) | Heteroaryl-substituierte piperidine | |
WO2008119457A3 (de) | Lactam-substituierte dicarbonsäuren und ihre verwendung | |
WO2010037066A3 (en) | Dosage units of 3-(6-(1-(2,2-difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid | |
WO2009033561A8 (de) | Substituierte 6-phenylnikotinsäuren und ihre verwendung | |
JO2756B1 (en) | The second preparation of aqueous pyrimidnon containing 4- (4-ciano-2-2 thiourail) and its use) | |
TN2011000466A1 (en) | Substituted 2-acetamido -5-aryl-1, 2, 4- triazolones and use thereof | |
WO2012076466A3 (de) | Substituierte 1-benzylcycloalkylcarbonsäuren und ihre verwendung | |
WO2008046581A3 (de) | Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln | |
WO2008155069A3 (de) | Substituierte oxazolidinone und ihre verwendung | |
WO2009076141A3 (en) | Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cycklopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid | |
WO2011127290A3 (en) | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid | |
WO2009050506A3 (en) | Combination 059 | |
IL216967A0 (en) | 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | |
WO2010078900A3 (de) | Neue aliphatisch substituierte pyrazolopyridine und ihre verwendung | |
ATE523510T1 (de) | Substituierte 4-aryl-1,4-dihydro-1,6- naphthyridine und ihre verwendung | |
WO2006063813A3 (de) | 3-arylalkyl-und-3-heteroarylalkyl-substituierte-1,2,4-triazin-5(2h)-one | |
WO2006063811A3 (de) | Substituierte 1,2,4-triazin-5(2h)-one | |
DOP2006000062A (es) | Derivados de acido pirimidincarboxilico y su uso | |
WO2009074247A8 (de) | Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel | |
WO2011009533A3 (de) | 17-hydroxy-17-pentafluorethyl-estra-4,9(10) -dien-11-ethinylphenyl-derivate, verfahren zu deren herstellung und deren verwendung zur behandlung von krankheiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07801996 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007801996 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2662879 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2009527717 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12440725 Country of ref document: US |